Delivery Order 36C25725D0009-36C25725N0083
Award Date
12/1/24
Potential Completion Date
11/30/25
Potential Value
$107K
Federal Agency
Veterans Integrated Service Network 17
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 22 of the U.S. Department of Veterans Affairs to Qiagen, LLC for the provision of QuantiFERON TB reagents. The contract has a ceiling value of $157,879.35 and a period of performance through March 31, 2017. Qiagen is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academia. Qiagen has provided a range...
This is a delivery order awarded to Qiagen, LLC, a subsidiary of Qiagen N.V., by the Veterans Integrated Service Network 9 (VISN 9) of the U.S. Department of Veterans Affairs. The contract is for the provision of QuantiFERON TB Gold Plus reagents, which are used for tuberculosis testing. The contract has a firm fixed price of $124,285.77 and a period of performance through September 30, 2024. This award is associated with a larger indefinite delivery/indefinite quantity (IDIQ) contract that...
This is a Firm Fixed Price Delivery Order awarded by the Veterans Integrated Service Network 17, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract, valued at $106,687.50, is for the supply of QuantiFERON-TB Gold Plus reagents. It is an Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a period of performance through November 30, 2026. The contract does not have a set-aside designation. Qiagen,...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer, under the VA's Medical and Surgical Products and Services (FSS-65-VII) schedule contract. The order is for QuantiFERON TB reagents, with a ceiling value of $253,316.50 and a period of performance through March 10, 2017. Qiagen is an established federal contractor, providing a range of products and services to support biomedical research, public health, and...
This is a Delivery Order awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Qiagen, LLC, a division of the international provider of molecular diagnostics and sample technologies Qiagen N.V. The $157,879.35 firm fixed price contract is for the provision of QuantiFERON tuberculosis test kits, which support the VA's healthcare programs. The contract is not set aside. Qiagen has held several multi-year indefinite delivery contracts and blanket purchase...
This federal contract award was issued by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $35,436.45 contract is for the procurement of QuantiFERON reagents, which are used for tuberculosis testing. This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order, with an ultimate completion date of August 31, 2028. Qiagen has provided similar...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 has awarded a $143,322 firm fixed price delivery order contract to Qiagen, LLC. The contract calls for Qiagen to provide Quantiferon and tubes with no set-aside designation. The period of performance is from October 1, 2022 through September 30, 2023. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle, though details of the base IDIQ are not...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Qiagen, LLC, a division of the international provider Qiagen N.V., for QUANTIFERON TB GOLD PLUS REAGENT. The $150,394.42 contract has a completion date of September 30, 2023 and does not have a set-aside designation. Qiagen is a manufacturer of molecular diagnostic products and services that supports federal agencies' biomedical research, public health, and healthcare programs. The...
This is a federal contract award by the Department of Veterans Affairs (VA) to Qiagen, LLC, a division of Qiagen N.V. The contract is for the delivery of QuantiFERON TB reagents, which are used for the diagnosis of tuberculosis infection. The contract has a ceiling value of $233,051.18 and a period of performance through February 15, 2018. This award is a delivery order placed under Qiagen's existing General Services Administration (GSA) Multiple Award Schedule contract for in-vitro diagnostics,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $0.00 firm fixed price delivery order against an indefinite-delivery/indefinite-quantity contract to Qiagen, LLC for Quantiferon and tubes. Qiagen, LLC is a subsidiary of Qiagen N.V. This order is for Quantiferon and tubes to support the agency's testing programs through September 30, 2021. No set-aside designation was applied to this award placed against an existing IDIQ contract...